Compare ARK Genomic Revolution ETF (ARKG) vs Illinois Tool Works Inc. (ITW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Illinois Tool Works Inc. — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Illinois Tool Works Inc. trades at $269.23 (market cap $77.34B). The key difference: Illinois Tool Works Inc. pays a 2.4% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Illinois Tool Works Inc. nearer its low. Which is the better fit depends on your goals.
| ARKG | ITW | |
|---|---|---|
Sector | Sector/Thematic | Industrials |
52-Week High | $43.57 | $299.60 |
52-Week Low | $23.09 | $241.07 |
Market Cap | — | $77.34B |
Enterprise Value | — | $85.66B |
Dividend Yield | — | 2.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
ITW trades at $268.81, up 1.25% with a bullish technical signal and strong profitability metrics including 19.32% net margin and 96.88% ROE. Recent earnings beats and a $1.61 dividend payment reflect operational strength, though cash flow trends show slight volatility. The stock is near resistance at $268 with analyst consensus target of $284.50.
Outlook remains positive with consistent earnings outperformance and margin expansion from enterprise initiatives. Risks include construction sector weakness and currency exposure. Wall Street shows mixed sentiment with 21% buy ratings, suggesting cautious optimism amid near-term headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Illinois Tool Works Inc.
Illinois Tool Works is a diversified global manufacturer that produces specialized industrial equipment, consumables, and related services. The firm operates 87 global divisions through seven distinct operating segments: automotive OEM, construction products, food equipment, specialty products, test/measurement and electronics, polymers and fluids, and welding. About half of its revenue comes from its operations in North America, with the remainder originating from international markets. ITW takes a bottom-up and decentralized approach to portfolio management, with the exception that each segment must apply its 80/20 operating process modeled on the Pareto principle.
Read more on ITW →
